Patent details

300691 Product Name: Albiglutide

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300691
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1463751
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300691
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/908
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/03/2014
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
18/09/2014
First Marketing Authorization date:
26/03/2014
Grant date:
01/12/2016
Activation date:
23/12/2022
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
09/11/2015
SPC/SPC Extension Expiration Date:
22/12/2027
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
03/10/2014
 
 

 

Name:
GlaxoSmithKline Intellectual Property Limited
Address:
980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)

Historical Applicant/holder

From:
18/09/2014
To:
03/10/2014

 

Name:
Human Genome Sciences, Inc.
Address:
14200 Shady Grove Road, ROCKVILLE, MD 20850, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
18/09/2014
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
31/21
Publication date:
04/08/2021
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
49/16
Publication date:
07/12/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
46/15
Publication date:
11/11/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
CO
Journal edition number:
2015/10
Publication date:
04/03/2015
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
SPC
Journal edition number:
2014/40
Publication date:
01/10/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
023245-A023245-1
Date Registered:
03/10/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
31/12/2022
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
01/12/2016 Outgoing Correspondence Decision grant 1 PDF /1/9/6/0/0/0400300691/docs/300691_4_outgoingcorrespondence20161202022950926.pdf
01/12/2016 SPC Documents Certificate SPC 1 PDF /1/9/6/0/0/0400300691/docs/300691_8_supplprotectioncertificate20161202022951012.pdf
23/11/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /1/9/6/0/0/0400300691/docs/300691_7_incomingcorrespondencepaper20210315043103228.pdf
13/10/2016 Outgoing Correspondence Letter to applicant 2 PDF /1/9/6/0/0/0400300691/docs/300691_9_outgoingcorrespondence20161014095032820.pdf
24/09/2014 Outgoing Correspondence Outgoing Letter 1 PDF /1/9/6/0/0/0400300691/docs/300691_1_outgoingcorrespondence20140924.pdf
18/09/2014 Application Form First filed application form 3 PDF /1/9/6/0/0/0400300691/docs/300691_0_applicationform20140918.pdf
18/09/2014 SPC Documents Marketing Authorization SPC 3 PDF /1/9/6/0/0/0400300691/docs/300691_2_supplprotectioncertificate20201021034803087.pdf
18/09/2014 SPC Documents Summary of the characteristics of the product 43 PDF /1/9/6/0/0/0400300691/docs/300691_3_supplprotectioncertificate20201021035358787.pdf
18/09/2014 SPC Documents Accompanying letter SPC 2 PDF /1/9/6/0/0/0400300691/docs/300691_5_supplprotectioncertificate20201021035118172.pdf
18/09/2014 SPC Documents Annex SPC 1 PDF /1/9/6/0/0/0400300691/docs/300691_6_supplprotectioncertificate20201021034939955.pdf